MicroRNAs (miRNAs) represent an emerging class of promising biomarkers for cancer diagnostics. To perform reliable miRNA expression analysis using qPCR, adequate data normalisation is essential to remove non-biological, technical variations. Ideal reference genes should be 1) biologically stable and 2) reduce technical variability of miRNA expression analysis.
A STRATEGY TO FIND SUITABLE REFERENCE GENES FOR MIRNA QUANTITATIVE PCR ANALYSIS AND ITS APPLICATION TO CERVICAL SPECIMENS INTRODUCTION
The rapid emergence of high throughput molecular profiling studies on cancer has resulted in the identification of numerous tumour biomarkers 1 . In recent years, differentially expressed microRNAs (miRNAs) have emerged as a highly promising class of biomarkers for cancer diagnostics 2, 3 . miRNAs are small non-coding RNAs that regulate gene expression of many protein-coding genes 4 and their deregulation has been implicated in several types of cancer, including cervical cancer 5 . A number of studies have reported altered miRNA expression patterns in cervical cancer cell lines 6, 7 and cervical cancer tissues 5, 8, 9 and many research efforts are currently focused on unraveling their functional role in cervical carcinogenesis. Interestingly, the existence of well-organised cervical screening programs facilitates the rapid translation of this knowledge into miRNA-based screening applications.
In The Netherlands, screening for cervical cancer by cytological examination of cervical scrapes has recently been replaced by primary testing for high-risk HPV (hrHPV) and various other countries will follow in the near future 10, 11 . Moreover, cervicovaginal self-sampling devices (hereafter referred to as self-samples) will be offered to women not attending the regular screening programme to increase screening coverage 12 . Since hrHPV-based screening also detects women with irrelevant transient infections, additional disease markers are required to identify women who need immediate referral for cervical (pre-)cancerous disease. Because cytology is subjective, has limited sensitivity and cannot be performed on self-samples, molecular markers such as disease-associated miRNAs have been suggested as alternatives 13 .
A major challenge, however, remains the development of a reliable high-throughput molecular test 14 . Quantitative PCR-based methods are highly sensitive, specific and reproducible, and are therefore commonly employed for the detection of cancer biomarkers. Quantitative reverse transcription PCR (RT-qPCR) permits the accurate measurement of small differences in RNA In case of qPCR assays, these variations can be introduced due to differences in amount and quality of starting material, RT efficiency and qPCR performance 21 . Inadequate normalisation can reduce or exaggerate the biological variability of the miRNA which in turn might lead to data misinterpretation and incorrect conclusions 22 .
At present, several strategies have been reported to correct for experimentally induced variations including normalizing to the mean of all analysed miRNAs 23 , quantile normalisation 24 and rank in-variant set normalisation 25 . Those data derived normalisation strategies, however, depend on measurements of large numbers of genes. They are therefore not applicable to smallscale qPCR analysis where only a few genes are tested, as is commonly the case in a clinical setting. Use of a few stably expressed endogenous control genes for normalisation has been demonstrated to successfully reduce data variation and is now generally acknowledged as the method of choice for qPCR data normalisation 21, 23, 26 .
In order to accurately eliminate experimentally introduced technical variation, an ideal reference gene panel should satisfy two conditions:
1) It should hardly compress or inflate the biological variability of the marker.
2) It should compress the technical variability of the marker miRNA.
The first condition can only be satisfied when the biological variation of the reference genes is small. This explains why most normalisation software tools strive for 'stable' reference genes.
For the second condition, however, the reference gene needs to reflect the technical variation between samples instead of being completely stable. Based on the fact that reproducibility is reduced and technical PCR noise is dramatically increased when amplifying low-copy transcripts [27] [28] [29] , a reference gene needs to satisfy a third condition:
3) It should be sufficiently abundant.
In reality, it is highly questionable whether a general reference gene panel exists for different sample types and conditions. Therefore, it is of crucial importance that reference genes are selected and validated according to the nature of the study, including experimental conditions and sample type. The reference gene selection and validation process, however, is not trivial.
While literature is plentiful, published selection procedures barely overlap. This general lack of consensus and the multitude of available algorithms for the assessment of biological variability make the decision how to approach the quest for reference genes even more difficult than the final choice of reference genes itself. In addition, most published studies only evaluate biological stability of candidate reference genes but fail to show that normalisation to those reference genes indeed reduces technical variation.
importantly and often underappreciated, the evaluation of suitable reference genes for miRNA qPCR data ( Fig.1 ). Moreover, we demonstrate its applicability on cervical fresh frozen tissue samples and impure diagnostic samples containing less lesional cells, namely cervical scrapes and lavage self-samples. We included different types of cervical specimens with different disease grades to acquire insight into the biological stability of selected reference genes in these distinct cervical specimens. Self-samples are particularly challenging due to the large overrepresentation of non-disease related cells, among others normal cervical epithelial cells, vaginal epithelial cells and lymphocytes. A panel of 11 candidate reference genes was selected from genome-wide miRNA profiling data of cervical tissues 5 and self-samples (manuscript in preparation) and literature 22, [30] [31] [32] . Expression stability of the 11 candidate reference genes was assessed using the statistical tools GeNorm 26 , NormFinder 33 and BestKeeper 34 and the effect of normalisation was evaluated by calculation of signal-to-noise ratios and resulting P values.
MATERIALS AND METHODS

Clinical cervical specimens
Cervical tissue samples consisted of microdissected fresh frozen specimens of 10 normal cervical epithelial samples, 11 high-grade cervical intraepithelial neoplasia (CIN2/3) lesions and 9 cervical squamous cell carcinoma (SCC) previously used for miRNA microarray 5 . Cervical scrapes were obtained from a screening population in the Utrecht region of The Netherlands that were collected between January 2010 and December 2011. These comprised scrapes stored in ThinPrep medium (Hologic, Vilvoorde, Belgium) of 15 women without underlying disease and 15 women with CIN3.
Self-collected cervicovaginal specimens (self-samples) included lavage self-samples collected using the Delphi Screener (Delphi Bioscience, Scherpenzeel, The Netherlands) and stored in ThinPrep medium from 12 women without cervical disease, 12 women with underlying CIN3 lesions and 6 women with underlying SCC that were available from the PROHTECT-3 study 35 .
This study followed the ethical guidelines of the Institutional Review Board of the VU University Medical Center and samples were used in an anonymous fashion in accordance with the 'Code for Proper Secondary Use of Human Tissues in the Netherlands' as formulated by the Dutch Federation of Medical Scientific Organisations 36 .
Selection of candidate reference genes
We selected small nuclear RNA U6 and small nucleolar RNAs RNU24, RNU43, RNU6B and U75 as potential reference genes based on previous studies not carried out in cervical samples 22, [30] [31] [32] . Next to this we used in-house available genome-wide miRNA profiles of 1) cervical lavage self-samples (small RNA sequencing, manuscript in preparation) and 2) fresh frozen tissue biopsies (microarray 5 ) of women with and without (pre)cancerous disease to select biologically stably expressed miRNAs. From our small RNA sequencing data candidate reference miRNAs were selected by first applying edgeRs TMM normalisation 37 and then selecting the miRNAs with a median expression (log2-transformed read counts) larger than 25 and the smallest standard deviations. The latter is an indicator that these miRNAs correlate well with the TMM normalisation factor. Microarray data were normalised as previously described 5 . We determined the miRNAs with the smallest differences between sample groups (normal, CIN2/3, SCC and adenocarcinoma) by calculating the median expression value (log2-transformed probe intensities) of every sample group and arithmetically averaging the difference in median expression between each possible combination of two groups. Only miRNAs with median expression levels larger than 5.5 were considered. Based on these datasets hsa-miR-30b-5p, hsa-miR-378i, hsa-miR-423-3p, hsa-miR-425-5p, hsa-miR-605 and hsa-miR-631-5p, were selected. In addition, we included synthetic miRNA cel-miR-239b-5p (miRIDIAN microRNA Mimic Negative Control #2; Dharmacon, Lafayette, United States) as spike-in to account for possible inhibition of reverse transcription and/or PCR.
RNA isolation
Total RNA was isolated using Trizol reagent (ThermoFisher Scientific, Bleiswijk, The Netherlands) according to the manufacturer's instructions. Small RNA concentration was measured using the Qubit® microRNA Assay kit on a Qubit® 2.0 Fluorometer (both ThermoFisher Scientific).
Quantitative RT-PCR (qPCR)
To ensure reliable and reproducible qPCR results, this study was performed in compliance with the 'minimum information for publication of quantitative real-time PCR experiments' (MIQE) guidelines 21 , where applicable.
Expression of RNU24, RNU43, RNU6B, U6, U75, hsa-miR-100-5p, hsa-miR-15b-5p, hsa-miR-30b-5p, hsa-miR-378i, hsa-miR-423-3p, hsa-miR-425-5p, hsa-miR-605, hsa-miR-631 and cel-miR-239b-5p was determined using TaqMan microRNA assays (001001, 001095, 001093, 001973, 001219, 000437, 000390, 464668_mat, 000602, 002626, 001516, 001568, 001564, 008188_mat; Thermo Fisher Scientific). The manufacturer's protocol was adapted in order to multiplex reverse transcription of all 14 targets and validated in comparison to singleplex reverse transcription reactions (data not shown). In short, the specific reverse transcription primers were combined in a primer pool and cDNA was synthesised in 16 µl reactions containing 
Data analysis
Gene expression stability was evaluated using the GenEx software version 6 (multiD Analyses, Göteborg, Sweden), in which two algorithms are implemented: NormFinder 33 and GeNorm 26 .
Additionally, BestKeeper 34 , which is Excel-based, was obtained from http://www.genequantification.com/bestkeeper.html (software version 1, last accessed 23 Feb 2017). To combine the outcome of all three programs, candidate reference genes were assigned consecutively numbered ranks for each algorithm, where 1 represents the most stable gene. A 'mean rank' was calculated as the average of the ranks assigned by each of the three algorithms and was used to assess overall gene stability 38, 39 . The Pearson correlation coefficient r was calculated based on Cq values to assess correlation between the two best ranked reference genes for each sample group. The selected reference genes were further evaluated by calculating the pooled standard deviation as measure of reproducibility.
Expression of marker genes hsa-miR-15b-5p (upregulated) and hsa-miR-100-5p (downregulated) was normalised to the geometric mean of the selected reference genes applying the 2 "#$ % method 40 . We employed a two-sample t-statistic to compare log2-transformed expression levels (log-expression) between normal and (pre-)cancerous specimens. Signal-to-noise ratios were calculated as the ratio of difference in mean miRNA log-expression between two groups to their according pooled standard deviation.
Theoretical considerations
An ideal reference gene panel should satisfy two conditions:
1) It should hardly compress or inflate the biological variability of the marker miRNA.
1)
To check the first condition, the biological variance of the normalised target log-expression, "#$%,'(% , , can be calculated as follows:
where k is the number of reference genes, "#,%&' and "#,%&# denote the biological variability in the marker miRNA and the reference gene, and the mean biological correlation amongst the reference genes and the mean biological correlation between the reference genes and the marker miRNA are denoted by ̅ #$,#$,&'$ and ̅ #$,&',()' , respectively. Since (mean) correlations vary between -1 and 1, we see that condition 1) is satisfied when the biological variation of the reference gene, "#,%&# , , is small.
2) To satisfy the second condition, the technical biases of reference gene and marker miRNA need to correlate well. This can be shown by computing the technical variance of the logtransformed normalised expression of a marker miRNA, "#$%,"' . If we assume that the technical variance of any miRNA log-expression, either marker miRNA or reference gene, equals 03 "#$%,"' = "#,"' + +
So, indeed the technical variance may be compressed if ̅ #$,&',#( is large. In addition, we observe that it is beneficial to use multiple reference genes (k > 1), preferably with orthogonal
STRATEGY AND RESULTS
Our strategy for the selection and evaluation of suitable reference genes for miRNA qPCR data is shown in Figure 1 .
Step 1: Selection of candidate reference genes
• Select from whole miRNome profiling study and/or literature. • At least 3 genes, ideally 5-10 32 .
• Include at least two miRNAs of interest.
Step 2: Selection of samples
• Representing all biological groups of interest; i.e. normal (healthy/untreated), case (disease/treated).
Step 4: RT-qPCR
Step
5: Exclusion of lowly abundant candidate reference genes
Exclude genes:  for which more than 75% of all samples (3 rd quartile) have a Cq value above a certain threshold Here: C q Threshold = 31.0.
Step 6: Selection of biologically most stable reference genes
Analysis of expression stability with available algorithms (NormFinder 32 , GeNorm 25 , BestKeeper 33 ).  Combine results by ranking candidate reference genes per algorithm and calculating the mean rank 37 .  Exclude genes that are significantly differentially expressed between groups of interest.
Step 7: Evaluation of biological correlation between reference genes
Perform linear regression on selected reference genes and calculate Pearson correlation coefficient (r).  Exclude lower ranked reference gene (Step 6) if r > 0.9.
Step 3: RNA extraction
• Include synthetic spike-in to account for RNA yield if RNA quantification is not feasible.
Step 8: Evaluation of technical variability of miRNA expression analysis
• Normalise miRNA qPCR data to the 2-3 most suitable reference genes and 2commonly used reference genes (e.g. U6 and RNU6B) or the 2 lowest ranked reference genes using the 2 -ΔCt method 39 . • Log2 transform normalised data and calculate signal-to-noise ratios and P values between biological groups. 
Step 1: Selection of candidate reference genes
Similar to qPCR studies analysing a few selected genes that might serve as biomarkers, we selected a panel of candidate reference genes either from whole miRNome profiling studies or literature (see Materials and Methods). Ideally, a list of 5 to 10 candidate reference genes should be analysed 33 . To to assess technical variability of the marker miRNA before and after normalisation (see Introduction condition 2; it should compress the technical variability of the marker miRNA), we recommend to analyse expression of at least two miRNAs of interest.
We selected RNU24, RNU43, RNU6B, U75, miR-30b, miR-378i, miR-423, miR-425, miR-605 and miR-631, as candidate reference genes based on literature 22, [30] [31] [32] and in-house available genome-wide miRNA profiles of women with and without (pre)cancerous disease ( Supplementary Fig. 1A, and B) . Although miRNAs miR-191-5p and miR-23a-3p have previously been suggested for miRNA normalisation in cervical tissue samples 32 , these were not added to our panel because they showed unstable expression across samples in our profiling data ( Supplementary Fig. 1C and D).
Step 2: Selection of samples Samples used to select reference genes should represent all biological groups of interest or experimental conditions, i.e. groups that will also be used for subsequent miRNA analysis such as healthy/disease or untreated/treated, hereafter referred to as biological groups. As for any other study, each biological group should be represented by an appropriate number of samples that needs to be determined for each study and largely depends on the heterogeneity of the biological groups 33 .
Inherent to its type of collection, less invasive sample types are more impure. Analysis of miRNA expression in cervical scrapes and self-samples has been proven challenging in the past, as those specimens are largely consisting of non-cervical cells (i.e. vaginal cells, lymphocytes) and normal cervical epithelial cells. Therefore, we included three types of cervical specimens, i.e. tissue samples (n=30), cervical scrapes (n=30) and self-samples (n=30) and compared the performance of candidate reference genes between these sample types. Ideally, we aim for a set of reference genes that can be utilised for miRNA qPCR data normalisation across all types of cervical specimens. To evaluate the expression levels of the candidate reference genes and marker miRNAs in cervical tissues, scrapes and self-samples, we included samples from women without underlying cervical disease and women with precancerous lesions (CIN2/3) and/or SCC.
Step 3 and 4: RNA extraction and qPCR
When low RNA extraction yields are expected and reliable RNA quantification is not possible, for instance when isolating circulating RNAs, a synthetic RNA molecule spiked into the sample prior to RNA extraction can control for RNA yield and RT input 41, 42 . Inclusion of such a 'spike-in' at a later point, for example into the RT reaction, can be used to correct for technical variation such as RT efficiency. However, it fails to account for RNA quality 42 and should therefore not be considered an appropriate reference gene. We quantified RNA concentrations and used the same amount of RNA as input for qPCR to keep experimental conditions as stable as possible.
Additionally, we included an exogenous spike-in synthetic control miRNA (cel-miR-239b) to control for potential technical variations introduced during RT and/or qPCR. Because it was previously shown that RNA integrity (RIN) does not affect miRNA quantification, RIN was not evaluated in our study 43 . Figure 2 shows the results of qPCR on tissue samples, cervical scrapes and self-samples for all 11 candidate reference genes and the spike-in. Amongst the candidate reference genes most variation was seen in self-samples. This may be explained by larger differences in vaginal contamination in self-samples, compared to tissues and scrapes (Fig. 2C ). As expected, we observed very low variation in measured levels of the spike-in control miRNA across all samples ( Fig. 2A-D) .
Moreover, low technical variation across all samples as indicated by overall low variation of measured spike-in levels was observed. This shows that addition of a synthetic spike-in is redundant when quantification of RNA concentrations is possible and therefore we excluded the spike-in from further analyses. 
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Step 5 [27] [28] [29] , this is a technical criterion that should be met in any case. However, this cutoff obviously needs to be adjusted to the nature of the study.
Based on this criterion, miR-631 was excluded for all sample types ( Fig. 2A-C) . In addition, RNU6B and miR-605 were excluded for cervical scrapes and self-samples ( Fig. 2B and C) and miR-425 for cervical scrapes (Fig. 2B) . RNU6B, miR-425, miR-605 and miR-631 were excluded from an analysis combining samples from all three sample types (Fig. 2D ).
Step 6: Selection of biologically most stable reference genes
The remaining candidate genes were assessed for their suitability as reference genes using the commonly employed algorithms NormFinder 33 , GeNorm 26 Unlike BestKeeper and GeNorm, however, NormFinder also takes the use of multiple genes for normalisation into consideration and indicates the optimal number of reference genes determined by the accumulated standard deviation (SD). Based on the accumulated SD ( Supplementary Fig. S2A-C) , we decided to select the 2 biologically most stable genes for cervical scrapes and the 3 biologically most stable genes for self-samples. For cervical tissues
NormFinder suggested the use of 5 biologically stable genes for normalisation. However, since there was only a slight decrease of the accumulated SD when more than 2 genes were considered, we decided to select the 2 highest ranked reference genes. This observation supports our assumption that 2-3 reference genes provide sufficiently robust normalisation.
We then summarised the results obtained from the three distinct algorithms constructing a comprehensive ranking as initially suggested by Wang et al. 38, 39 : candidate reference genes are assigned consecutively numbered ranks for each algorithm, where rank 1 represents the most stable gene. Overall gene expression stability is subsequently ranked calculating a mean rank value for each gene. RNU24 in tissues, for example, was assigned rank 2 according to NormFinder results and ranked 3 rd by GeNorm and BestKeeper. The resulting mean rank ((2+3+3)/3) was 2.6.
Interestingly, miR-423 was ranked as one of the biologically most stable genes in all types of cervical specimens as well as in all samples combined when the mean rank for each candidate reference gene was calculated ( Table 1 ). Based on those results we selected miR-423 and RNU24 as reference genes for cervical tissues, RNU43 and miR-423 for cervical scrapes and miR-423, RNU43 and miR-30b for self-samples.
Moreover, we excluded candidate reference genes that are significantly differentially expressed between biological groups. While those candidates might be biologically stable across all samples, their inter-group variation could potentially skew results when using them for normalisation.
Because RNU43 was significantly differently expressed between normal and CIN3/SCC selfsamples ( Table 2; P=0.01), we excluded it from further analysis in this sample type. NormFinder suggests the use of 3 reference genes for self-samples. However, the 4 th ranked gene in selfsamples, miR-378i, also showed a significant difference between the groups. Therefore, we decided to continue with the 2 biologically most stable genes, i.e. miR-423 and miR-30b, in self-samples. The remaining genes did not show a significant difference between normal controls and cases, and seemed suitable reference genes for the respective sample types.
Step 7: Evaluation of biological correlation between reference genes
Because a single reference gene possesses 'innate variability' between individuals and/or experimental conditions it is recommended to use multiple internal controls to minimise this variability 44 . Subsequently, this could prove beneficial in reducing the technical variation of the marker miRNA (please refer to Materials and Methods; Theoretical considerations). However, when reference genes display very strong biological correlation (correlation coefficients between 0.9 and 1.0), and hence exhibit a near-identical biological expression pattern, their combination will be relatively ineffective in reducing the mean biological variability of the reference genes and consequently will hardly diminish the technical variation of the marker miRNA more than the individual reference genes. Therefore, we evaluated the correlation between the selected reference genes and only considered Pearson correlation coefficients r < 0.9 acceptable. If a given combination of reference genes exceeds this threshold, we suggest to return to step 6 and select the next biologically most stable reference gene(s) from the list of mean ranked reference genes.
In our data, we observed relatively strong correlation between reference genes for cervical tissues and self-samples ( Fig. 3A and C; r=0.836 and 0.863, respectively) while the reference genes in cervical scrapes displayed lower correlation ( Fig. 3B; r=0.555 ). As none of our selected combinations of reference genes displayed correlation coefficients r > 0.9, the combined use of the 2 biologically most stable reference genes should yield gain in minimizing the technical variability of the marker miRNA. Based on their stability values, reference genes were assigned consecutive ranks for each algorithm.
The comprehensive ranking was constructed calculating the mean rank for each reference gene. Pearson correlation coefficient (r) values are shown.
Step 8: Evaluation of technical variability of miRNA expression analysis
In order to evaluate the technical variability of miRNA expression analysis, we assessed the quantification of two marker miRNAs in biological group comparisons. We evaluated the quantification of the marker miRNAs using a combination of the 2 biologically most stable reference genes and 2 commonly used reference genes for miRNA expression analysis, which are U6 9, 22, 45 and RNU6B 22, 30, 32 . One may also consider using the 2 biologically least stable reference genes as determined by mean ranking. Both options are valid and one could be included to demonstrate the importance of carefully selecting suitable reference genes according to the nature of the study.
We here selected miR-15b and miR-100 as marker miRNAs since their deregulation is commonly described in cervical cancer 5, 7, 9 . Several studies have found upregulation of miR-15b in cervical cancer tissues 5, 7, 46 as well as cervical cancer cell lines 47 , while miR-100 is often found downregulated in cervical cancer specimens 5, 9, 46, 48, 49 . Figure 4 shows log2-transformed and centered expression data for miR-15b and miR-100 after normalizing to the according reference genes. Interestingly, normalisation with the 2 biologically most stable reference genes in cervical tissues resulted in improved quantification of miR-15b in normal versus CIN2/3 and SCC, which was not observed when using 2 commonly used reference genes, i.e. U6 and RNU6B (Fig. 4A) . For miR-100 we observed a better separation between normal and CIN2/3 as well as between normal and SCC in cervical tissues when the 2 biologically most stable reference genes were used for normalisation compared to normalisation to 2 commonly used reference genes. Moreover, for both miR-15b and miR-100 we observed lower variation (indicated by narrower boxplots) in the biological groups after normalisation with the 2 biologically most stable genes which was not observed after normalisation with 2 commonly used reference genes. For miR-15b and miR-100 in cervical scrapes, we observed no improvement in separating the groups when normalizing either to the 2 biologically most stable reference genes or 2 commonly used reference genes (Fig. 4B ). However, we did observe lower variation of the biological groups after normalisation with the 2 biologically most stable reference genes compared to 2 commonly used reference genes. Consistent with the results presented for cervical tissues, we found improved quantification of miR-15b and miR-100 after normalisation with the 2 biologically most stable reference genes in self-samples ( Fig. 4C) . Also, we observed a strong reduction of the variation in biological groups for miR-100 when normalised to the 2 biologically most stable reference genes compared to normalisation with U6 and RNU6B.
The technical variability of the reference genes (condition 2) is difficult to assess, unless technical replicates that mimic the technical variability (incl. sample quality) between biological samples are available. The latter requires dedicated experiments with deliberate perturbations of the sample quality e.g. by dilution or contamination. As a proxy, however, we consider the signal-tonoise ratio in combination with a t-statistic between biological groups of samples: if the technical noise is compressed and the biological differences are not (or hardly), this should lead to a larger signal-to-noise ratio and a smaller P value. Figure 5 shows P values and signal-to-noise ratios. While positive signal-to-noise ratios indicate upregulation, negative ones correspond to downregulation. Higher absolute signal-to-noise ratio values imply larger differences between the groups that are compared and are therefore desired. For exact P values and signal-to-noise ratios please refer to Supplementary Table S1 .
Interestingly, we obtained larger signal-to-noise ratios for miR-15b and miR-100 in almost all biological group comparisons and for every cervical specimen type when normalizing to the 2 biologically most stable reference genes compared to no normalisation. This consequently resulted in smaller P values. For miR-15b in tissues, however, we obtained similar or lower signalto-noise ratios when normalised to the 2 biologically most stable reference genes compared to no normalisation. Importantly, when comparing the signal-to-noise ratios and P values of miR-15b in tissues between the 2 normalisation strategies, we observed larger signal-to-noise ratios and much smaller P values for the 2 biologically most stable reference genes than for the 2 commonly used reference genes U6 and RNU6B. In total, we obtained 5 statistically significant results (P < 0.05) for 6 possible group comparisons in tissue samples when normalizing to our selected reference genes.
No normalisation and normalisation to U6 and RNU6B resulted in 4 and 3 significant group comparisons, respectively. Consistent with this observation, for the vast majority of biological group comparisons we observed larger signal-to-noise ratios and smaller P values for miR-15b
and miR-100 in scrapes as well as self-samples when normalised to the 2 biologically most stable reference genes compared to 2 commonly used reference genes. In self-samples, 3 comparisons between biological groups achieved significance after normalisation to the 2 biologically most stable genes, while no normalisation and normalisation to 2 commonly used reference genes led to 2 and 1 significant result, respectively.
Finally, to test the reproducibility of the normalisation panels we performed replicate measurements of the selected reference genes in all previously analysed cervical scrapes and self-samples by quadruplicate PCR (two individual RT reactions and four PCR reactions).
Subsequently, we calculated the pooled SD for each reference gene and found that all genes exhibited small pooled SD (< 0.5 Cq) across the four replicates. 
DISCUSSION
In order to perform reliable miRNA expression analysis using qPCR, suitable and robust data normalisation is essential to remove or minimise non-biological sample-to-sample variations introduced during the experimental procedure. In this study we successfully identify miR-423 as a suitable reference gene for all sample types, to be used in combination with RNU24 in cervical tissues, RNU43 in cervical scrapes and miR-30b in self-samples. Rather than suggesting the use of those reference genes for the normalisation of miRNA qPCR data in the respective cervical sample type, however, we propose a straight-forward strategy for the identification of suitable reference genes as outlined in Figure 1 . This strategy can be applied for every experimental design and all sample types without entailing excessive additional pilot experiments. After exclusion of lowly abundant genes, we used three commonly used algorithms, NormFinder 33 , GeNorm 26 and BestKeeper 34 to identify biologically stable reference genes. We summarised the results obtained from the three distinct methods constructing a comprehensive ranking 33 and Score represents the stability value of the gene in question calculated by the according algorithm 42 . While the comprehensive ranking consists of the averaging of the rank assigned by each algorithm, the SSS summarizes stability scores directly. Both approaches are valid and they will most likely lead to the selection of sets of largely overlapping reference genes.
Calculating the SSS for our data indeed led to comparable results as the comprehensive ranking ( Supplementary Table S2 ). Interestingly, individual NormFinder results were the most comparable to the results obtained by the comprehensive ranking: the two reference genes that were eventually selected for the different sample types were ranked 1 st and 2 nd by NormFinder.
While NormFinder was the best 'predictor' in our data, i.e. the most representative algorithm, we cannot rule out that this observation is due to chance. Because all 3 methods have their own strengths and weaknesses 50 , we still recommend the use of all three algorithms combined with the comprehensive ranking as unbiased approach for the selection of reference genes.
As mentioned before, a single reference gene possesses 'innate variability' that could be minimised by using multiple biologically stable reference genes 44 . The use of at least two reference genes has previously been suggested and it has been shown that normalisation with only one reference gene can result in erroneous normalisation and biased results 26, 51 . Unfortunately, it is not practical to use large numbers of reference genes for diagnostic purposes as time, money and clinical material are often limited. Here, we consider the use of 2-3 reference genes sufficient to provide robust normalisation without increasing workload disproportionally to the experimental design. In support of this decision, the accumulated SD determined by NormFinder did not decrease greatly when more than two genes were considered ( Supplementary Fig. S2 ).
Pursuing our strategy we selected 2 reference genes for each sample type and demonstrated that normalizing to those genes indeed reduced sample-to-sample variation (Fig. 4 ). Most studies, however, only focus on the identification of biologically stable reference genes and neglect technical variability of both reference genes and genes of interest. In the most extreme case, normalisation to a seemingly completely stable gene would equal normalizing to a constant. A constant, however, obviously fails to account for technical noise. This theoretical example illustrates that technical variability of candidate reference genes needs to be assessed.
Because such an assessment would entail large experiments that are usually not feasible, we here calculated signal-to-noise ratios and P values as proxy. While normalizing to the selected reference genes generally increased signal-to-noise ratios, normalizing to U6 and RNU6B, two genes that are commonly used in literature, even introduced variation and compressed signalto-noise ratios.
This demonstrates that poor normalisation can have dramatic effects on a study's outcome and that common reference genes should not be used without prior experimental validation [52] [53] [54] .
To the best of our knowledge, this is the first study on the selection of reference genes in cervical scrapes and self-samples. Notably, our results show that reference genes need to be selected individually for different types of specimens originating from the same anatomical source. This is probably related to varying degrees of sample purity. Microdissected tissue samples represent the purest sample type, while self-samples are assumed to contain the most impure material due to contamination with non-disease related cells, such as vaginal epithelial cells and lymphocytes.
In fact, expression variation of every candidate reference gene was larger in self-samples than in tissues and scrapes ( Fig. 2A-C) . This observation is also reflected by the generally higher stability measures in self-samples compared to scrapes, while stability values are the lowest in tissue samples (Table 1 ). An analysis combining all tested specimens and the difference in performance of miR-30b and miR-378i in scrapes and self-samples further demonstrate that reference genes need to be selected for individual sample types and stress the importance of dedicated reference gene selection experiments.
Interestingly, miR-30b, miR-378i and miR-423 were initially selected as candidate reference genes based on our in-house small RNA sequencing data on self-samples (manuscript in preparation), showing that biologically stable genes can be identified in available whole miRNome-wide data. On the other hand, miR-631 which was selected from our microarray data on cervical tissues 5 was excluded from all sample types because of high Cq values. However, this is most likely a technical issue as we observed amplification artefacts in all samples. High Cq values obtained for RNU6B are in concordance with observations previously reported by Kok et al. 54 and again indicate that common reference genes do not provide reliable normalisation in every experimental setup.
While we observed a minor reduction in variation for miR-15b in cervical scrapes after normalizing to the 2 biologically most stable reference genes, normalisation had no effect on P values. It is likely that our initial selection of reference genes did not include suitable reference genes for this sample type. We therefore expect the analysis of additional candidate reference genes to result in the identification of more appropriate reference genes for cervical scrapes.
Selecting candidate reference genes based on whole miRNome-wide data obtained in scrapes offers a promising approach.
In conclusion, our study confirms that reference genes should not be used unconditionally without prior testing and that different sample types originating from the same anatomical source might require different reference genes. Because reference gene selection is not trivial and literature is not conclusive, we here present a strategy to identify the most suitable reference genes in a pre-selected group of candidate reference genes. Importantly, we show that our comprehensive strategy is well suited for impure diagnostic samples. Finally, our strategy may serve as a guideline for the selection and evaluation process of suitable reference genes and can improve data normalisation in future qPCR studies that aim to identify the most discriminatory miRNA markers between biological groups. 
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